The interim recommendations for use of the use of the Janssen Ad26.COV2.S (COVID-19) vaccine have been updated to
reflect latest evidence.For further information, see below:Interim recommendations for use of the the Janssen Ad26.COV2.S (COVID-19) vaccine against COVID-19
Updated interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
Published in All WHO news
More from All WHO newsMore posts in All WHO news »
- UN Commission approves WHO recommendations to place psychoactive substances under international control
- Frank, in-depth discussion as Belgium and WHO map ahead priorities for collaboration
- WHO and Switzerland cement cooperation until 2028
- WHO announces new collaborating centre on AI for health governance